Jay Luly
Chief Executive Officer bij ENANTA PHARMACEUTICALS, INC.
Vermogen: 14 M $ op 31-03-2024
Profiel
Jay R.
Luly is the President, Chief Executive Officer & Director of Enanta Pharmaceuticals, Inc. He previously held positions as Director at Artesian Therapeutics, Inc., SVP-Drug Discovery & Pre-Clinical Development at Abbott Laboratories, Senior VP-Research & Development Operations at Millennium Pharmaceuticals, Inc., and Senior VP-Drug Discovery & Preclinical Development at LeukoSite, Inc. He also served as a Trustee at The Boston Biomedical Research Institute.
Luly holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-02-2024 | 810 609 ( 3.83% ) | 14 M $ | 31-03-2024 |
Actieve functies van Jay Luly
| Bedrijven | Functie | Begin |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01-07-2003 |
Eerdere bekende functies van Jay Luly
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| The Boston Biomedical Research Institute | Director/Board Member | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Director/Board Member | - |
Opleiding van Jay Luly
| University of California, Berkeley | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
| The Boston Biomedical Research Institute |
